A review of eligibility for patients with central nervous system (CNS) metastases from non-small cell lung cancer (NSCLC) in immunotherapy clinical trials

Saba S. Shaikh*, Priya U Kumthekar, Nisha Anjali Mohindra

*Corresponding author for this work

Research output: Contribution to journalLetter

Original languageEnglish (US)
Pages (from-to)235-237
Number of pages3
JournalJournal of Neuro-Oncology
Volume144
Issue number1
DOIs
StatePublished - Aug 15 2019

Fingerprint

Non-Small Cell Lung Carcinoma
Immunotherapy
Central Nervous System
Clinical Trials
Neoplasm Metastasis

ASJC Scopus subject areas

  • Oncology
  • Neurology
  • Clinical Neurology
  • Cancer Research

Cite this

@article{31c4fcafd78846a298498b2f3d040daa,
title = "A review of eligibility for patients with central nervous system (CNS) metastases from non-small cell lung cancer (NSCLC) in immunotherapy clinical trials",
author = "Shaikh, {Saba S.} and Kumthekar, {Priya U} and Mohindra, {Nisha Anjali}",
year = "2019",
month = "8",
day = "15",
doi = "10.1007/s11060-019-03219-7",
language = "English (US)",
volume = "144",
pages = "235--237",
journal = "Journal of Neuro-Oncology",
issn = "0167-594X",
publisher = "Kluwer Academic Publishers",
number = "1",

}

TY - JOUR

T1 - A review of eligibility for patients with central nervous system (CNS) metastases from non-small cell lung cancer (NSCLC) in immunotherapy clinical trials

AU - Shaikh, Saba S.

AU - Kumthekar, Priya U

AU - Mohindra, Nisha Anjali

PY - 2019/8/15

Y1 - 2019/8/15

UR - http://www.scopus.com/inward/record.url?scp=85068308501&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85068308501&partnerID=8YFLogxK

U2 - 10.1007/s11060-019-03219-7

DO - 10.1007/s11060-019-03219-7

M3 - Letter

C2 - 31240523

AN - SCOPUS:85068308501

VL - 144

SP - 235

EP - 237

JO - Journal of Neuro-Oncology

JF - Journal of Neuro-Oncology

SN - 0167-594X

IS - 1

ER -